b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">\n        <PMID Version="1">30270644</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>12</Month>\n            <Day>06</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>12</Month>\n            <Day>17</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1724-6016</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>29</Volume>\n                    <Issue>6</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Nov</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>European journal of ophthalmology</Title>\n                <ISOAbbreviation>Eur J Ophthalmol</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Lacrimal sac lymphoma: A series of Japanese patients.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>678-684</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1177/1120672118803510</ELocationID>\n            <Abstract>\n                <AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">To present cases of primary lacrimal sac lymphoma in a Japanese population.</AbstractText>\n                <AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this retrospective case series, five cases (two males and three females; mean age: 49.8\xe2\x80\x89years; age range: 38-62\xe2\x80\x89years) were included. Clinical features, diagnostic findings, and treatment outcomes were collected and reviewed.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Most patients presented with a swelling or mass in the medial canthal area. Only one patient presented with epiphora, while another patient also complained of pain which was due to inflammation. Imaging studies revealed a lacrimal sac mass with involvement of the nasolacrimal duct and variable involvement of the nasal cavity. Histopathological findings revealed three cases of diffuse large B-cell lymphoma, one case of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, and one case of follicular lymphoma. Four cases were treated with a combination of chemotherapy and immunotherapy, with one case necessitating additional radiotherapy. One case was treated with immunotherapy alone. The mean follow-up was 23 (range: 3-50)\xe2\x80\x89months. Four cases showed complete remission, while the remaining patient is still ongoing treatment.</AbstractText>\n                <AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Diffuse large B-cell lymphoma is the most common type of lacrimal sac lymphoma in this series. Lacrimal sac tumors should be ruled out in the presence of epiphora, dacryocystitis, or a mass in the medial canthus, even in the absence of pain or bleeding. Combined chemotherapy and immunotherapy is an effective treatment for these cases.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Sabundayo</LastName>\n                    <ForeName>Maria Suzanne</ForeName>\n                    <Initials>MS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oculoplastic, Orbital &amp; Lacrimal Surgery, Aichi Medical University Hospital, Nagakute, Japan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Takahashi</LastName>\n                    <ForeName>Yasuhiro</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oculoplastic, Orbital &amp; Lacrimal Surgery, Aichi Medical University Hospital, Nagakute, Japan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kakizaki</LastName>\n                    <ForeName>Hirohiko</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oculoplastic, Orbital &amp; Lacrimal Surgery, Aichi Medical University Hospital, Nagakute, Japan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>01</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Eur J Ophthalmol</MedlineTA>\n            <NlmUniqueID>9110772</NlmUniqueID>\n            <ISSNLinking>1120-6721</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005134" MajorTopicYN="N">Eye Neoplasms</DescriptorName>\n                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007167" MajorTopicYN="N">Immunotherapy</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007766" MajorTopicYN="N">Lacrimal Apparatus Diseases</DescriptorName>\n                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018442" MajorTopicYN="N">Lymphoma, B-Cell, Marginal Zone</DescriptorName>\n                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008224" MajorTopicYN="N">Lymphoma, Follicular</DescriptorName>\n                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016403" MajorTopicYN="N">Lymphoma, Large B-Cell, Diffuse</DescriptorName>\n                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011878" MajorTopicYN="N">Radiotherapy</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Japanese</Keyword>\n            <Keyword MajorTopicYN="N">Lacrimal sac lymphoma</Keyword>\n            <Keyword MajorTopicYN="N">diffuse large B-cell lymphoma</Keyword>\n            <Keyword MajorTopicYN="N">follicular lymphoma</Keyword>\n            <Keyword MajorTopicYN="N">mucosa-associated lymphoid tissue</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>18</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>2</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30270644</ArticleId>\n            <ArticleId IdType="doi">10.1177/1120672118803510</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'